rs760543068
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_000719.7(CACNA1C):c.3790G>A(p.Val1264Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,612,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1C | NM_000719.7 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | ENST00000399655.6 | NP_000710.5 | |
| CACNA1C | NM_001167623.2 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | ENST00000399603.6 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
| CACNA1C | ENST00000399655.6 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
| CACNA1C | ENST00000682544.1 | c.3940G>A | p.Val1314Met | missense_variant | Exon 30 of 50 | ENSP00000507184.1 | ||||
| CACNA1C | ENST00000406454.8 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 48 | 5 | ENSP00000385896.3 | |||
| CACNA1C | ENST00000399634.6 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 5 | ENSP00000382542.2 | |||
| CACNA1C | ENST00000683824.1 | c.3955G>A | p.Val1319Met | missense_variant | Exon 30 of 48 | ENSP00000507867.1 | ||||
| CACNA1C | ENST00000347598.9 | c.3850G>A | p.Val1284Met | missense_variant | Exon 30 of 49 | 1 | ENSP00000266376.6 | |||
| CACNA1C | ENST00000344100.7 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000341092.3 | |||
| CACNA1C | ENST00000327702.12 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 48 | 1 | ENSP00000329877.7 | |||
| CACNA1C | ENST00000399617.6 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 48 | 5 | ENSP00000382526.1 | |||
| CACNA1C | ENST00000682462.1 | c.3880G>A | p.Val1294Met | missense_variant | Exon 29 of 47 | ENSP00000507105.1 | ||||
| CACNA1C | ENST00000683781.1 | c.3880G>A | p.Val1294Met | missense_variant | Exon 29 of 47 | ENSP00000507434.1 | ||||
| CACNA1C | ENST00000683840.1 | c.3880G>A | p.Val1294Met | missense_variant | Exon 29 of 47 | ENSP00000507612.1 | ||||
| CACNA1C | ENST00000683956.1 | c.3880G>A | p.Val1294Met | missense_variant | Exon 29 of 47 | ENSP00000506882.1 | ||||
| CACNA1C | ENST00000399638.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 48 | 1 | ENSP00000382547.1 | |||
| CACNA1C | ENST00000335762.10 | c.3865G>A | p.Val1289Met | missense_variant | Exon 30 of 48 | 5 | ENSP00000336982.5 | |||
| CACNA1C | ENST00000399606.5 | c.3850G>A | p.Val1284Met | missense_variant | Exon 30 of 48 | 1 | ENSP00000382515.1 | |||
| CACNA1C | ENST00000399621.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382530.1 | |||
| CACNA1C | ENST00000399637.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382546.1 | |||
| CACNA1C | ENST00000402845.7 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000385724.3 | |||
| CACNA1C | ENST00000399629.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382537.1 | |||
| CACNA1C | ENST00000682336.1 | c.3865G>A | p.Val1289Met | missense_variant | Exon 30 of 47 | ENSP00000507898.1 | ||||
| CACNA1C | ENST00000399591.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 46 | 1 | ENSP00000382500.1 | |||
| CACNA1C | ENST00000399595.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 46 | 1 | ENSP00000382504.1 | |||
| CACNA1C | ENST00000399649.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 46 | 1 | ENSP00000382557.1 | |||
| CACNA1C | ENST00000399597.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382506.1 | |||
| CACNA1C | ENST00000399601.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382510.1 | |||
| CACNA1C | ENST00000399641.6 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382549.1 | |||
| CACNA1C | ENST00000399644.5 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | 1 | ENSP00000382552.1 | |||
| CACNA1C | ENST00000682835.1 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 47 | ENSP00000507282.1 | ||||
| CACNA1C | ENST00000683482.1 | c.3781G>A | p.Val1261Met | missense_variant | Exon 29 of 47 | ENSP00000507169.1 | ||||
| CACNA1C | ENST00000682686.1 | c.3790G>A | p.Val1264Met | missense_variant | Exon 29 of 46 | ENSP00000507309.1 | ||||
| CACNA1C | ENST00000480911.6 | n.*2397G>A | non_coding_transcript_exon_variant | Exon 27 of 27 | 5 | ENSP00000437936.2 | ||||
| CACNA1C | ENST00000480911.6 | n.*2397G>A | 3_prime_UTR_variant | Exon 27 of 27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000560 AC: 14AN: 250188 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460816Hom.: 0 Cov.: 29 AF XY: 0.0000179 AC XY: 13AN XY: 726830 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Long QT syndrome Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1264 of the CACNA1C protein (p.Val1264Met). This variant is present in population databases (rs760543068, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 456967). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1C protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at